Skip to main content

oncology management

Feature
08/17/2017
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
Abstract: Multiple myeloma (MM) is a progressive and fatal disease, primarily affecting men aged 66 years or older. Because MM is primarily a disease of the elderly, it is incumbent on geriatricians and primary care...
...
08/17/2017
Journal of Clinical Pathways
Research in Review
06/15/2017
JCP Editors
Better symptom management and readily available outpatient care for patients with cancer can reduce emergency department (ED) visits that do not require admission by as much as 53%, according to a recent...
Better symptom management and readily available outpatient care for patients with cancer can reduce emergency department (ED) visits that do not require admission by as much as 53%, according to a recent...
Better...
06/15/2017
Journal of Clinical Pathways
05/16/2017
JCP Editors
Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...
Recommended primary treatment for non-muscle invasive micropapillary urothelial carcinoma (MPBC) is often foregone in community cancer centers and academic centers, according to a study presented at the American...
...
05/16/2017
Journal of Clinical Pathways
Research in Review
12/16/2016
JCP Editors
New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...
New consensus guidelines provide a "road map" for the appropriate implementation of imaging biomarkers in clinical practice. ----- Related Content Biomarkers Predict Cetuximab Performance in Metastatic Colorectal...
New...
12/16/2016
Journal of Clinical Pathways
Research in Review
11/15/2016
JCP Editors
While clinical pathways have emerged as a way of reducing care variability and standardizing best practice, some institutions that implement these tools still face difficulties with physician buy-in and adherence to...
While clinical pathways have emerged as a way of reducing care variability and standardizing best practice, some institutions that implement these tools still face difficulties with physician buy-in and adherence to...
While...
11/15/2016
Journal of Clinical Pathways
Research in Review
11/10/2016
JCP Editors
Tivozanib was well-tolerated and showed promising antitumor activity in patients with soft tissue sarcoma overexpressing vascular endothelial growth factors (VEGF), supporting efforts for further research, according...
Tivozanib was well-tolerated and showed promising antitumor activity in patients with soft tissue sarcoma overexpressing vascular endothelial growth factors (VEGF), supporting efforts for further research, according...
...
11/10/2016
Journal of Clinical Pathways
Quiz
11/03/2016
JCP Editors
While previously reported as a promising biomarker for bladder cancer, a recent study published in Cancer found that which of the following was not a reliable predictor of cancer progression or treatment...
While previously reported as a promising biomarker for bladder cancer, a recent study published in Cancer found that which of the following was not a reliable predictor of cancer progression or treatment...
...
11/03/2016
Journal of Clinical Pathways
Research in Review
09/06/2016
JCP Editors
Pediatric oncology and stem cell transplant patients with ambulatory bloodstream infections have higher health care costs and unplanned extended hospital admissions, claims a recent study. ----- Related...
Pediatric oncology and stem cell transplant patients with ambulatory bloodstream infections have higher health care costs and unplanned extended hospital admissions, claims a recent study. ----- Related...
...
09/06/2016
Journal of Clinical Pathways
Research in Review
06/15/2016
JCP Editors
Researchers from the department of radiation oncology at the VU University Medical Center in Amsterdam, the Netherlands, have proposed a novel formula for the optimization of radiosurgery dose for any given lesion...
Researchers from the department of radiation oncology at the VU University Medical Center in Amsterdam, the Netherlands, have proposed a novel formula for the optimization of radiosurgery dose for any given lesion...
...
06/15/2016
Journal of Clinical Pathways
Research in Review
03/08/2016
JCP Editors
A study has shown that a high number of patients struggle to adhere to oral antineoplastic therapies as prescribed by their provider. Antineoplastic agents are oral drugs that help to halt the process of cell...
A study has shown that a high number of patients struggle to adhere to oral antineoplastic therapies as prescribed by their provider. Antineoplastic agents are oral drugs that help to halt the process of cell...
A...
03/08/2016
Journal of Clinical Pathways